EnEvolv, Inc., a Boston, MA-based genome engineering company, completed its $1.7m Series A financing.
The round was led by Cultivian Sandbox Venture Partners, LP, a Chicago-based venture capital firm.
The company will utilize these new funds to expand research and development and business development activities.
Co-founded by and Marco Farsheed, Chief Executive Officer, George Church of Harvard Medical School and Farren Isaacs of Yale University, EnEvolv leverage a proprietary genome engineering platform built on Multiplex Automated Genome Engineering (MAGE) technology to develop and license microorganisms to produce chemicals, enzymes, and small molecules for pharmaceuticals, personal care, specialty chemicals, food, and energy industries.
The company collaborates with major companies to engineer novel microorganisms and improve their existing strains to increase production yield and product quality.
The company also appointed Ron Meeusen, Ph.D. is a Managing Director of Cultivian Sandbox and co-founder and Managing Partner of Cultivian Ventures, and Charles L. Cooney, Ph.D., the Robert T. Haslam (1911) Professor of Chemical and Biochemical Engineering in the Department of Chemical Engineering at MIT and the Faculty Director of the Deshpande Center for Technological Innovation, to its Board of Directors.
FinSMEs
13/03/2014